-
Views
-
Cite
Cite
Zhihui Wang, Veronika Bordas, Jonathan Sagotsky, Thomas S. Deisboeck, Identifying therapeutic targets in a combined EGFR–TGFβR signalling cascade using a multiscale agent-based cancer model, Mathematical Medicine and Biology: A Journal of the IMA, Volume 29, Issue 1, March 2012, Pages 95–108, https://doi.org/10.1093/imammb/dqq023
- Share Icon Share
Abstract
Applying a previously developed non-small cell lung cancer model, we assess ‘cross-scale’ the therapeutic efficacy of targeting a variety of molecular components of the epidermal growth factor receptor (EGFR) signalling pathway. Simulation of therapeutic inhibition and amplification allows for the ranking of the implemented downstream EGFR signalling molecules according to their therapeutic values or indices. Analysis identifies mitogen-activated protein kinase and extracellular signal-regulated kinase as top therapeutic targets for both inhibition and amplification-based treatment regimen but indicates that combined parameter perturbations do not necessarily improve the therapeutic effect of the separate parameter treatments as much as might be expected. Potential future strategies using this in silico model to tailor molecular treatment regimen are discussed.